- £59.61m
- £51.94m
- £55.81m
- 81
- 50
- 97
- 92
Annual income statement for Synectics, fiscal year end - November 30th, GBP millions except per share, conversion factor applied.
2020 November 30th | R2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 44.6 | 36.6 | 39.1 | 49.1 | 55.8 |
| Cost of Revenue | |||||
| Gross Profit | 14.6 | 14.1 | 16.6 | 20 | 23.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 50.8 | 37.1 | 38.6 | 46.4 | 51.5 |
| Operating Profit | -6.15 | -0.454 | 0.494 | 2.75 | 4.26 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.29 | -0.558 | 0.361 | 2.65 | 4.17 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.67 | -0.442 | 0.639 | 2.16 | 3.18 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4.67 | -0.479 | 1.47 | 2.16 | 3.18 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.67 | -0.479 | 1.47 | 2.16 | 3.18 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.192 | -0.049 | 0.081 | 0.15 | 0.217 |
| Dividends per Share |